Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À¯¹æ¾Ï¿¡¼­ HMGI(Y) À¯ÀüÀÚ ¹ßÇö ¹× º´¸® Á¶Á÷ÇÐÀû °ü°è¿¡ ´ëÇÑ ¿¬±¸ The Expression of High Mobility Group I (Y) Proteins in Human Breast Cancer

´ëÇÑ¿Ü°úÇÐȸÁö 2001³â 60±Ç 2È£ p.136 ~ 140
·ùÁø¿ì,
¼Ò¼Ó »ó¼¼Á¤º¸
·ùÁø¿ì ( Ryu Jin-Woo ) 
´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract


Purpose: The precise mechanisms of tumorigenesis of breast cancer remains unknown in spite of major efforts. Recent studies have shown that High Mobility Group I (Y) Proteins [HMGI(Y)] have an important role in the regulation of chromatin structure and function, and that HMGI(Y) protein expression is generally correlated with a malignant phenotype. This study was undertaken to define the relationship of the HMGI(Y) protein expression between malignant breast tissue and non-malignant breast tissue in human, and clinico- pathologic findings were reviewed for this purpose.

Methods: Using Reverse Transcription-Polymerase Chain Reaction (RT-PCR) for HMGI(Y) with ¥â-actin, this study demonstrated the expression of HMGI(Y). The p53, ER, and PR. were defined by immunohistochemical staining.

Results: The HMGI(Y) expression was increased in the malignant tissue (90%), than in benign (76.9%) or normal (65%) tissue (p=0.031). As for the invasive ductal cancers, there was no difference between the HMGI(Y) expression and histopathologic parameters.

Conclusion: These results suggest that the HMGI(Y) expression may be of little pathogenetic prognostic importance in human breast cancer.

Å°¿öµå

HMGI(Y);À¯¹æ¾Ï
HMGI(Y);Breast cancer

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS